These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1674024)

  • 21. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.
    Meek SR; Doberstyn EB; Gaüzère BA; Thanapanich C; Nordlander E; Phuphaisan S
    Am J Trop Med Hyg; 1986 Mar; 35(2):246-50. PubMed ID: 3513642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
    Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
    Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
    Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
    MacArthur J; Stennies GM; Macheso A; Kolczak MS; Green MD; Ali D; Barat LM; Kazembe PN; Ruebush TK
    Am J Trop Med Hyg; 2001 Dec; 65(6):679-84. PubMed ID: 11791956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mefloquine level monitoring in patients with multidrug resistant Plasmodium falciparum on the Thai Myanmar border.
    Karbwang J; Bangchang KN; Thimasarn K; Rooney W; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):505-7. PubMed ID: 8160060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
    Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
    Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
    Lell B; Lehman LG; Schmidt-Ott JR; Sturchler D; Handschin J; Kremsner PG
    Am J Trop Med Hyg; 1998 May; 58(5):619-24. PubMed ID: 9598451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
    Thimasarn K; Sirichaisinthop J; Vijaykadga S; Tansophalaks S; Yamokgul P; Laomiphol A; Palananth C; Thamewat U; Tháithong S; Rooney W
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):204-12. PubMed ID: 8629047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
    Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
    Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract]   [Full Text] [Related]  

  • 37. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
    Malin AS; Hall AP
    BMJ; 1990 May; 300(6733):1175. PubMed ID: 2189516
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
    Myint PT; Shwe T
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.